Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-07

FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved a supplemental application to add Aleve GelCaps (naproxen sodium) as a new dosage form for the Aleve product line, expanding the brand’s formulatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALEVE GELCAPS (NAPROXEN SODIUM)

Snippet

SUPPL AP for ALEVE GELCAPS (NAPROXEN SODIUM)